- Home
- IIPR vs OCUL Comparison
IIPR vs OCUL Comparison
Compare IIPR & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IIPR | OCUL |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IIPR | OCUL |
|---|---|---|
| Price | $57.53 | $10.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $45.00 | $23.56 |
| AVG Volume (30 Days) | 238.1K | ★ 2.8M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 14.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | N/A |
| Revenue | ★ $265,955,000.00 | $1,990,000.00 |
| Revenue This Year | $2.69 | $7.93 |
| Revenue Next Year | $3.80 | $96.07 |
| P/E Ratio | $23.46 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $44.58 | $6.23 |
| 52 Week High | $65.38 | $16.44 |
Technical Indicators
Market Signals| Indicator | IIPR | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 42.40 | 63.71 |
| Support Level | $56.13 | $7.96 |
| Resistance Level | $57.36 | $11.50 |
| Average True Range (ATR) | 1.15 | 0.50 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 46.75 | 79.19 |
Price Performance
Historical ComparisonAbout IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.